Other Posts
Every year Larvol comes together for Tiger day where we showcase a wide variety of talents from both Larvol Tigers and their families.
Here at Larvol, we refer to our team members as tigers. This year, we celebrated our 4th annual Tiger Day where we come together on one big Zoom meeting and watch a variety of submitted videos from team members performing a talent. People can also opt to film their children, or junior tigers, performing or showcasing a talent. This years video capped off at 35 minutes of submissions filled with the talent of our team and their families.
We witnessed beautifully choreographed dances, singing, photography, paintings, art, and even baking! As a fully remote team, we don’t always have the opportunity to come together and Tiger Day gives us the chance to “meet”. This meeting takes our long distance work relationships and shrinks them in a way that truly makes it feel like we are all in the room together.
Larvol turned 15 this year and this company is filled with outstanding people and it was an absolute pleasure to watch everyone in their video submissions. We laughed, cried, and were mesmerized by what our team can do! It was nice to have a meeting with the full team that was mainly focused on getting to know each other. Tiger Day is very special to us and we look forward to what 2020 will bring!
79% had reduction in disease. ORR 31%. Many responses deepen over time.
Toxicity profile was in line with prior TIL/Lifileucel data. No surprises here. Median # doses of IL-2 was 6.
Absolutely agree!… this should be available to our melanoma patients ASAP!… and paves the way for smarter cellular therapies to be designed, studied, and eventually widely disseminated
Just before I start AM clinic at @cityofhopeoc, excited to share results from #COBALT_RCC, a P1 trial of @CRISPRTX#CTX130 in #kidneycancer in the @sitcancer#PressProgram. Will present more on Thurs 5:37p at #SITC22! Thx @neerajaiims@DrBenTran@HaanenJohn#SamerSrour& co-Is! t.co/aDnhG9n92A
@montypal@cityofhopeoc@CRISPRTX@sitcancer@neerajaiims@DrBenTran@HaanenJohn@DrChoueiri@TiansterZhang@tompowles1@brian_rini@AlbigesL@Uromigos@ERPlimackMD@drenriquegrande@PGrivasMDPhD Congrats Monty! Looking forward to hearing about this exciting first-in the field study!
CAR-Ts are coming for #kidneycancer!! Congratulations @montypal and team; can’t wait to see results at #SITC22! t.co/9MrlF2yzBe
Congrats @montypal and team! Great to see CAR T therapy coming to #RCCt.co/ypRHBC89Pt
Another huge step from none other than @montypal!! CAR-Ts in #kidneycancer!Congratulations to the entire team!Looking forward to seeing the results at #SITC22! t.co/HvKeVBPyV7
@montypal you never stop to amaze me! You are brilliant & awesome! Looking forward to hearing more about this trial @sitcancer@OncoAlert@CityofHope_GU@COHMDCareers@neerajaiims@KidneyCancer@KidneyCancerDoc@NazliDizman@ZeynepZengin@LuisMezaco@crisbergerot@PauloBergerott.co/RNzOwxixQm
